The Cost and Public Health Burden of Invasive Meningococcal Disease Outbreaks: A Systematic Review

被引:23
|
作者
Anonychuk, Andrea [1 ,2 ,3 ]
Woo, Gloria [4 ]
Vyse, Andrew [1 ]
Demarteau, Nadia [1 ]
Tricco, Andrea C. [5 ]
机构
[1] GlaxoSmithKline Vaccines, Wavre, Belgium
[2] Abbott Labs, Div Diagnost, Abbott Pk, IL 60064 USA
[3] Abbott Labs, Div Diagnost, Mississauga, ON L5N 3R3, Canada
[4] Univ Toronto, Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada
[5] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada
关键词
NEISSERIA-MENINGITIDIS; CONJUGATE VACCINE; UNITED-STATES; SEROGROUP; IMMUNOGENICITY; POLYSACCHARIDE; SAFETY; W-135; INFECTION; ENGLAND;
D O I
10.1007/s40273-013-0057-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background Invasive meningococcal disease (IMD) is a serious disease with a rapid onset, high mortality rate, and risk of long-term complications. Numerous reports in the literature conclude that IMD outbreaks are associated with substantial costs to society and significant burden on communities due to the cost associated with the prevention of secondary cases. Objective To systematically review the literature on the costs and public health burden associated with IMD outbreaks. Methods Studies were primarily identified through searching MEDLINE and EMBASE. Reports were included if they provided cost data related to the containment of an IMD outbreak after 1990 and were written in English, French, or Spanish. Costs were converted to 2010 United States dollars. Outbreaks were categorized by low-income countries (LIC) and high-income countries (HIC) based on gross domestic product per capita. Outbreak containment strategies were classified as small (e.g., targeting members of the school/institution where the outbreak occurred) or large (e.g., targeting everyone in the community). Results Sixteen articles reporting data on 93 IMD outbreaks fulfilled the eligibility criteria and were included. The majority of outbreaks occurred in HIC. Five studies reported the use of small containment strategies including targeted vaccination and chemoprophylaxis, all occurring in HIC. The average cost per small containment strategy was $299,641 and the average cost per IMD case was $41,857. Eight studies reported large containment strategies involving widespread vaccination targeting a specific age group or community. For HIC, the average cost per large containment strategy was $579,851 and the average cost per IMD case was $55,755. In LIC, the average cost per large containment strategy was $3,407,590 and the average cost per IMD case was $2,222. Conclusion IMD outbreaks were associated with substantial costs. We found that although there were numerous reports on IMD outbreaks, data on containment costs were very limited. More research in this area is warranted.
引用
收藏
页码:563 / 576
页数:14
相关论文
共 50 条
  • [21] Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysis
    Presa, Jessica Vespa
    de Almeida, Rodrigo Sini
    Spinardi, Julia Regazzini
    Cane, Alejandro
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 80 : 137 - 146
  • [22] INVASIVE MENINGOCOCCAL DISEASE ECONOMIC BURDEN: A COMPREHENSIVE ANALYSIS
    Langevin, E.
    Lesage, H.
    Juniper, M.
    VALUE IN HEALTH, 2023, 26 (12) : S198 - S198
  • [23] CLINICAL AND ECONOMIC BURDEN OF INVASIVE MENINGOCOCCAL DISEASE IN FRANCE
    Fievez, S.
    Htar, Tin Tin M.
    Goguillot, M.
    Benard, S.
    Huang, L.
    VALUE IN HEALTH, 2018, 21 : S224 - S225
  • [24] Invasive Neisseria meningitidis disease outbreaks and epidemics: role of meningococcal vaccines
    Krizova, P.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S22 - S22
  • [25] A Comprehensive Review of Meningococcal Disease Burden in India
    Ashok Kumar Dutta
    Subramanian Swaminathan
    Veronique Abitbol
    Shafi Kolhapure
    Sripriya Sathyanarayanan
    Infectious Diseases and Therapy, 2020, 9 : 537 - 559
  • [26] A Comprehensive Review of Meningococcal Disease Burden in India
    Dutta, Ashok Kumar
    Swaminathan, Subramanian
    Abitbol, Veronique
    Kolhapure, Shafi
    Sathyanarayanan, Sripriya
    INFECTIOUS DISEASES AND THERAPY, 2020, 9 (03) : 537 - 559
  • [27] Alcohol consumption’s attributable disease burden and cost-effectiveness of targeted public health interventions: a systematic review of mathematical models
    Ariel Esteban Bardach
    Andrea Olga Alcaraz
    Agustín Ciapponi
    Osvaldo Ulises Garay
    Andrés Pichón Riviere
    Alfredo Palacios
    Mariana Cremonte
    Federico Augustovski
    BMC Public Health, 19
  • [28] Alcohol consumption's attributable disease burden and cost-effectiveness of targeted public health interventions: a systematic review of mathematical models
    Esteban Bardach, Ariel
    Olga Alcaraz, Andrea
    Ciapponi, Agustin
    Ulises Garay, Osvaldo
    Pichon Riviere, Andres
    Palacios, Alfredo
    Cremonte, Mariana
    Augustovski, Federico
    BMC PUBLIC HEALTH, 2019, 19 (01)
  • [29] The health burden of preventable disease in Australia: a systematic review
    Crosland, Paul
    Ananthapavan, Jaithri
    Davison, Jacqueline
    Lambert, Michael
    Carter, Rob
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2019, 43 (02) : 163 - 170
  • [30] A Systematic Review and Provisional Metanalysis on Psychopathologic Burden on Health Care Workers of Coronavirus Outbreaks
    Galli, Federica
    Pozzi, Gino
    Ruggiero, Fabiana
    Mameli, Francesca
    Cavicchioli, Marco
    Barbieri, Sergio
    Canevini, Maria Paola
    Priori, Alberto
    Pravettoni, Gabriella
    Sani, Gabriele
    Ferrucci, Roberta
    FRONTIERS IN PSYCHIATRY, 2020, 11